AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis
Authors: Perrillo, RP Wright, T Rakela, J Levy, G Schiff, E Gish, R Martin, P Dienstag, J Adams, P Dickson, R Anschuetz, G Bell, S Condreay, L Brown, N
Citation: Rp. Perrillo et al., A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis, HEPATOLOGY, 33(2), 2001, pp. 424-432
Clinical significance of elevated alpha-fetoprotein in adults and children
Authors: Kashyap, R Jain, A Nalesnik, M Carr, B Barnes, J Vargas, HE Rakela, J Fung, J
Citation: R. Kashyap et al., Clinical significance of elevated alpha-fetoprotein in adults and children, DIG DIS SCI, 46(8), 2001, pp. 1709-1713
Changes in hepatitis C virus population in serum and peripheral blood mononuclear cells in chronically infected patients receiving liver graft from infected donors.
Authors: Radkowski, M Wang, LF Vargas, H Wilkinson, J Rakela, J Laskus, T
Citation: M. Radkowski et al., Changes in hepatitis C virus population in serum and peripheral blood mononuclear cells in chronically infected patients receiving liver graft from infected donors., TRANSPLANT, 72(5), 2001, pp. 833-838
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection
Authors: Molmenti, EP Jain, AB Shapiro, R Scantlebury, V Lee, R Totsuka, E Flohr, J Rakela, J Fung, JJ
Citation: Ep. Molmenti et al., Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection, TRANSPLANT, 71(2), 2001, pp. 267-271
Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain
Authors: Laskus, T Wang, LF Radkowski, M Vargas, H Nowicki, M Wilkinson, J Rakela, J
Citation: T. Laskus et al., Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain, J VIROLOGY, 75(5), 2001, pp. 2059-2066
Exposure of hepatitis C virus-negative recipients to >= 2 infected blood donors
Authors: Laskus, T Wang, LF Radkowski, M Nowicki, M Wilkinson, J Rakela, J
Citation: T. Laskus et al., Exposure of hepatitis C virus-negative recipients to >= 2 infected blood donors, J INFEC DIS, 183(4), 2001, pp. 666-669
Transplant livers in Wilson's disease for hepatic, not neurologic, indications - Response
Authors: Eghtesad, B Fung, JJ Rakela, J
Citation: B. Eghtesad et al., Transplant livers in Wilson's disease for hepatic, not neurologic, indications - Response, LIVER TRANS, 6(5), 2000, pp. 663-664
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation
Authors: Dodson, SF de Vera, ME Bonham, CA Geller, DA Rakela, J Fung, JJ
Citation: Sf. Dodson et al., Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation, LIVER TRANS, 6(4), 2000, pp. 434-439
Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria
Authors: Shakil, AO Kramer, D Mazariegos, GV Fung, JJ Rakela, J
Citation: Ao. Shakil et al., Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria, LIVER TRANS, 6(2), 2000, pp. 163-169
Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: Effect of viral hepatitis D
Authors: Taniguchi, M Shakil, AO Vargas, HE Laskus, T Demetris, AJ Gayowski, T Dodson, SF Fung, JJ Rakela, J
Citation: M. Taniguchi et al., Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: Effect of viral hepatitis D, LIVER TRANS, 6(1), 2000, pp. 92-96
Quality of life in long-term survivors after liver transplantation: impactof recurrent viral hepatitis C virus hepatitis
Authors: Paterson, DL Gayowski, T Wannstedt, CF Wagener, MM Marino, IR Vargas, H Laskus, T Rakela, J Singh, N
Citation: Dl. Paterson et al., Quality of life in long-term survivors after liver transplantation: impactof recurrent viral hepatitis C virus hepatitis, CLIN TRANSP, 14(1), 2000, pp. 48-54
Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure
Authors: Shakil, AO Jones, BC Lee, RG Federle, MP Fung, JJ Rakela, J
Citation: Ao. Shakil et al., Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure, DIG DIS SCI, 45(2), 2000, pp. 334-339
Late-onset renal failure after liver transplantation: Role of posttransplant alcohol use
Authors: Gayowski, T Singh, N Keyes, L Wannstedt, CF Wagener, MM Vargas, H Laskus, T Rakela, J Fung, JJ Marino, IR
Citation: T. Gayowski et al., Late-onset renal failure after liver transplantation: Role of posttransplant alcohol use, TRANSPLANT, 69(3), 2000, pp. 383-388
Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: Confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication
Authors: Laskus, T Radkowski, M Wang, LF Nowicki, M Rakela, J
Citation: T. Laskus et al., Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: Confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication, J VIROLOGY, 74(2), 2000, pp. 1014-1017
Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: Evidence of active replication in monocytes/macrophages and lymphocytes
Authors: Laskus, T Radkowski, M Piasek, A Nowicki, M Horban, A Cianciara, J Rakela, J
Citation: T. Laskus et al., Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: Evidence of active replication in monocytes/macrophages and lymphocytes, J INFEC DIS, 181(2), 2000, pp. 442-448
Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects
Authors: Radkowski, M Kubicka, J Kisiel, E Cianciara, J Nowicki, N Rakela, J Laskus, T
Citation: M. Radkowski et al., Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects, BLOOD, 95(12), 2000, pp. 3986-3989
Liver transplantation for Wilson's disease: A single-center experience
Authors: Eghtesad, B Nezakatgoo, N Geraci, LC Jabbour, N Irish, WD Marsh, W Fung, JJ Rakela, J
Citation: B. Eghtesad et al., Liver transplantation for Wilson's disease: A single-center experience, LIVER TR S, 5(6), 1999, pp. 467-474
Primary adult liver transplantation under tacrolimus: More than 90 months actual follow-up survival and adverse events
Authors: Jain, AB Kashyap, R Rakela, J Starzl, TE Fung, JJ
Citation: Ab. Jain et al., Primary adult liver transplantation under tacrolimus: More than 90 months actual follow-up survival and adverse events, LIVER TR S, 5(2), 1999, pp. 144-150
Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization
Authors: Kim, WR Wiesner, RH Poterucha, JJ Therneau, TM Malinchoc, M Benson, JT Crippin, JS Klintmalm, GBG Rakela, J Starzl, TE Krom, RAF Evans, RW Dickson, ER
Citation: Wr. Kim et al., Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization, HEPATOLOGY, 30(2), 1999, pp. 395-400
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation
Authors: Perrillo, R Rakela, J Dienstag, J Levy, G Martin, P Wright, T Caldwell, S Schiff, E Gish, R Villeneuve, JP Farr, G Anschuetz, G Crowther, L Brown, N
Citation: R. Perrillo et al., Multicenter study of lamivudine therapy for hepatitis B after liver transplantation, HEPATOLOGY, 29(5), 1999, pp. 1581-1586
Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: A cost effective strategy for prevention of cytomegalovirus disease inadult liver transplant recipients
Authors: Kusne, S Grossi, P Irish, W St George, K Rinaldo, C Rakela, J Fung, J
Citation: S. Kusne et al., Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: A cost effective strategy for prevention of cytomegalovirus disease inadult liver transplant recipients, TRANSPLANT, 68(8), 1999, pp. 1125-1131
Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors
Authors: Dodson, SF Bonham, CA Geller, DA Cacciarelli, TV Rakela, J Fung, JJ
Citation: Sf. Dodson et al., Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors, TRANSPLANT, 68(7), 1999, pp. 1058-1061
Hepatitis C virus in peripheral blood mononuclear cells from a chronicallyinfected patient receiving liver graft from infected donor
Authors: Radkowski, M Wang, LF Vargas, H Rakela, J Laskus, T
Citation: M. Radkowski et al., Hepatitis C virus in peripheral blood mononuclear cells from a chronicallyinfected patient receiving liver graft from infected donor, TRANSPLANT, 67(4), 1999, pp. 627-629
Foundling viruses and transfusion medicine
Authors: Mosley, JW Rakela, J
Citation: Jw. Mosley et J. Rakela, Foundling viruses and transfusion medicine, TRANSFUSION, 39(10), 1999, pp. 1041-1044
Liver transplantation for metabolic liver diseases
Authors: Khanna, A Jain, A Eghtesad, B Rakela, J
Citation: A. Khanna et al., Liver transplantation for metabolic liver diseases, SURG CL NA, 79(1), 1999, pp. 153
Risultati: 1-25 | 26-34